Skip to content

Efficacy and safety of the topical isoflavone product on the facial skin in male participants: a randomized controlled trial

Efficacy and safety of the topical isoflavone product on the facial skin in male participants: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240312001
Enrollment
80
Registered
2024-03-12
Start date
2024-06-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy male participants Isoflavones male skin face

Interventions

Topical isoflavone product applied 0.3 mL twice daily on the facial skin,Topical product without active ingredients applied 0.3 mL twice daily on the facial skin
Active Comparator Other,Placebo Comparator Other
Topical isoflavone product,Placebo

Sponsors

Chiang Mai University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Age between 45-65 years at the screening visit; 2. Has a body mass index (BMI) of 18-30 kg/m2; 3. Has no reaction to the skin allergy test; and 4. Able to read and write Thai.

Exclusion criteria

Exclusion criteria: 1. Has a treatment with estrogen hormone or isoflavones within 6 months prior to the screening visit; 2. Has a history of periorificial dermatitis, skin cancer or skin cancer on the face, skin infection, and/or serious comorbidities; 3. Has any physical attributes or skin conditions that might interfere with the clear visual (i.e., cuts, sunburn, birth marks, tattoos, extensive scarring, excessive hair growth or acne); 4. Uses a drug(s), herb(s), vitamin(s), mineral(s), or dietary supplement(s) and/or other ingredients regularly in the investigational product that may affect the facial skin within 30 days; 5. Has a history of hypersensitivity to soy products and/or any other ingredients in the investigational product; 6. Uses soy protein isolate, soy protein concentrate, or soy-isoflavone enrichment regularly within 30 days; 7. Uses a topical anti-wrinkle treatment course or any aesthetic cosmetic course within 30 days; 8. Participates in another clinical trial concurrently or within 30 days prior to the screening visit; 9. Has a history of smoking or substance abuse within the past 3 months; and 10. Has a history of alcoholism or consumption of pure alcohol > 35 g/day (5 % alcohol) > 710 mL/day, wine (12 % alcohol) > 296 mL/day, or alcoholic beverages (40% alcohol) > 89 mL/day within the past 3 months.

Design outcomes

Primary

MeasureTime frame
The absolute mean change in skin parameters 0,4,8,12 weeks Non-invasive instruments for skin parameter measurement

Secondary

MeasureTime frame
Satisfaction evaluation 4, 8, 12 weeks Satisfaction questionaire,Adverse events 4, 8, 12 weeks Reporting

Countries

Thailand

Contacts

Public ContactMingkwan Na Takuathung

Faculty of Medicine, Chiang Mai University

mingkwan.n@cmu.ac.th053934592

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026